Health Technology Innovations, Inc. news

Health Technology Innovations, Inc. (HTI) is excited to announce that Dr. Doug Kawahara is joining HTI as Senior Advisor for AI/ML in Drug Discovery. Dr. Kawahara brings extensive experience in drug discovery and development to HTI. He is currently President & CEO of Elex Biotech (Portland, OR), a company developing novel drugs for the treatment of arrhythmia and heart failure. Previously, Dr. Kawahara was Executive Vice President, Corporate Development for Oligos Etc. (Wilsonville,

Health Technology Innovations, Inc. (HTI) today announced that Dr. Jeff King is joining HTI as a Senior Advisor. Dr. King is CEO and co-founder of Virogenomics BioDevelopment, Inc. (VBD), a biotechnology research and development company that collaborates extensively with scientists at Oregon Health and Science University (OHSU) who are developing technology with potential commercial applications. Prior to founding VBD Dr. King was Director of Bioinformatics and later COO and CEO of Viro